Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...
Abbott’s latest CE mark for its TactiFlex Duo system was based on a clinical trial conducted in the European Union, United ...
Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...
Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...
Startups raised $14.2 billion last year, the highest funding total since 2022. Health AI companies collected 54% of total ...
With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...
An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...
The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...
The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff ...
From insurance coverage questions to M&A and tariffs, here are the top storylines to watch in the medical device space in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results